BEACHWOOD -- Wet Age-Related Macular Degeneration, or AMD, is one of the leading causes of severe vision loss in people age 40 years and older.
Nearly two million Americans over forty have it, and millions more are at risk for it.
The standard treatment is literally a needle in the eye. But a new clinical trial is testing a new type of drug that would may eliminate the need for the injection.
The drug is simply an eye drop. To learn more about the study, click HERE.
To learn more about AMD click HERE